Ledger.Open graph →

SEC Form D · Amendment · filed October 25, 2021

Cedilla Therapeutics, Inc

Offering

$82.6M

Sold

$82.6M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Chris Bowden · Cambridge, MADirector Neil Exter · Cambridge, MADirector Dominik Naczynski · Cambridge, MADirector Abbie Celniker · Cambridge, MADirector Rosana Kapeller · Cambridge, MADirector Eli Casdin · Cambridge, MADirector Alexandra Glucksmann · Cambridge, MAExec · Director Jeffrey Davison · Bethlehem, PADirector Amir Achourie · Los Angeles, CAExec · Director Paul Stern · Vancouver, British Columbia, CanadaDirector Stephen Holler · Vancouver, British Columbia, CanadaDirector Yousaf Sami · Vancouver, British Columbia, CanadaDirector Michael M. Carroll · Richmond, VADirector Prashant Raj · Vancouver, British Columbia, CanadaDirector Jake Simson · Cambridge, MADirector Roann Costin · NEW YORK, NYDirector Alex Madkour · Seattle, WADirector EM Alpine Holdings, LLC · New York, NYDirector Daniel M. Labovitz · Gladstone, NJDirector Robert R. Wotzcak · Gladstone, NJDirector Charles R. Dolan · Gladstone, NJExec · Director Alexander R. Kontoleon · Gladstone, NJDirector Jake Simson · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗